Veterinary Medicines

Oestrophan inj. ad us. vet. 0, 25 mg /ml šķīdums injekcijām liellopiem, cūkām, zirgiem

Authorised
  • Cloprostenol sodium
Download as PDF

Product identification

Medicine name:
Oestrophan inj. ad us. vet. 0, 25 mg /ml šķīdums injekcijām liellopiem, cūkām, zirgiem
Active substance:
  • Cloprostenol sodium
Target species:
  • Cattle (cow)
  • Pig (sow)
  • Horse (mare)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Cloprostenol sodium
    0.25
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (cow)
      • Milk
        0
        day
      • Meat and offal
        1
        day
    • Pig (sow)
      • Meat and offal
        1
        day
    • Horse (mare)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG02AD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta, a.s.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/96/0389
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 5/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."